CN108420913A - A kind of Chinese medicine composition and preparation method thereof for treating asthma - Google Patents
A kind of Chinese medicine composition and preparation method thereof for treating asthma Download PDFInfo
- Publication number
- CN108420913A CN108420913A CN201810480307.4A CN201810480307A CN108420913A CN 108420913 A CN108420913 A CN 108420913A CN 201810480307 A CN201810480307 A CN 201810480307A CN 108420913 A CN108420913 A CN 108420913A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- parts
- asthma
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000006673 asthma Diseases 0.000 title claims abstract description 44
- 239000003814 drug Substances 0.000 title claims abstract description 41
- 239000000203 mixture Substances 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 241000967218 Selaginella tamariscina Species 0.000 claims abstract description 19
- 244000144725 Amygdalus communis Species 0.000 claims abstract description 15
- 235000011437 Amygdalus communis Nutrition 0.000 claims abstract description 15
- 241001465251 Ephedra sinica Species 0.000 claims abstract description 15
- 240000000249 Morus alba Species 0.000 claims abstract description 15
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 15
- 241001522129 Pinellia Species 0.000 claims abstract description 15
- 241000207929 Scutellaria Species 0.000 claims abstract description 15
- 241000249864 Tussilago Species 0.000 claims abstract description 15
- 235000020224 almond Nutrition 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 42
- 235000019441 ethanol Nutrition 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 239000002775 capsule Substances 0.000 claims description 22
- 239000000463 material Substances 0.000 claims description 20
- 239000000706 filtrate Substances 0.000 claims description 16
- 239000000843 powder Substances 0.000 claims description 14
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 12
- 239000012141 concentrate Substances 0.000 claims description 10
- 239000004375 Dextrin Substances 0.000 claims description 8
- 229920001353 Dextrin Polymers 0.000 claims description 8
- 235000019425 dextrin Nutrition 0.000 claims description 8
- 235000019640 taste Nutrition 0.000 claims description 7
- 230000006837 decompression Effects 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 238000004064 recycling Methods 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 13
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 210000004072 lung Anatomy 0.000 description 12
- 229940079593 drug Drugs 0.000 description 8
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 3
- 241001328788 Camellia nitidissima Species 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000218691 Cupressaceae Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000036428 airway hyperreactivity Effects 0.000 description 1
- 208000037883 airway inflammation Diseases 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003979 eosinophil Anatomy 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to tcm field, the Chinese medicine composition and preparation method thereof of specifically a kind for the treatment of asthma.The Chinese medicine composition is made of the raw material of following parts by weight：25 ~ 50 parts of Selaginella tamariscina, 15 ~ 30 parts of Chinese ephedra, 10 ~ 25 parts of the root bark of white mulberry, 10 ~ 20 parts of scutellaria, 20 ~ 30 parts of perillaseed, 15 ~ 30 parts of the tuber of pinellia, 1 ~ 10 part of almond, 10 ~ 15 parts of tussilago, 1 ~ 5 part of Radix Glycyrrhizae.Chinese medicine composition compatibility of the present invention is reasonable, safe and free of toxic and side effects, and no complication, preparation process is simple, significant in efficacy, is suitble to clinically large-scale use.
Description
Technical field
The present invention relates to tcm field, the Chinese medicine composition and preparation method thereof of specifically a kind for the treatment of asthma.
Background technology
Asthma be it is a kind of there are the diseases of airway constriction, caused by the airway hyperreactivity that certain inflammatory stimulus generate, roar
Asthma is a kind of common disease, frequently-occurring disease, is participated in by various kinds of cell especially mast cell, eosinophil and lymphocyte
Chronic airway inflammation, such inflammation can cause panting for recurrent exerbation in susceptible person, the symptoms such as shortness of breath, uncomfortable in chest and/or cough,
Small number of patients is also possible to pectoralgia be main performance.Incidence in adult is about 5%.Asthma has Familial aggregation tendency, grinds
Study carefully and show that the incidence of asthma in urban population is higher, and in Adults Asthma, the incidence higher of women.Such symptom
It is often accompanied by extensive and changeable airflow obstruction, can be reversed voluntarily or by treatment.Currently, medical field is to treating asthma without spy
Drug is imitated, it is palliative, so that many long-term illness of patient are not cured, prodigious physiology and psychological pressure are caused to patient.
Treatment asthma although the treatment works well for it, will produce mainly by the way of western medicine at present
Certain toxic side effect, and cannot tackling the problem at its root, it is very high thus to cause this kind of palindromia rate, to suffering from
Person brings prodigious stress.
Invention content
It is an object of the invention to overcome the defect of problem above, provide a kind of Selaginella tamariscina be used to treat asthma capsule and
Preparation method.
For achieving the above object, the present invention uses following technical scheme：
A kind of Chinese medicine composition for treating asthma, the Chinese medicine composition are made of the raw material of following parts by weight：Selaginella tamariscina 25 ~ 50
Part, 15 ~ 30 parts of Chinese ephedra, 10 ~ 25 parts of the root bark of white mulberry, 10 ~ 20 parts of scutellaria, 20 ~ 30 parts of perillaseed, 15 ~ 30 parts of the tuber of pinellia, 1 ~ 10 part of almond,
10 ~ 15 parts of tussilago, 1 ~ 5 part of Radix Glycyrrhizae.
Further, the dosage form of the Chinese medicine composition is capsule.
The preparation method for treating the Chinese medicine composition of asthma, includes the following steps：
(1) by Selaginella tamariscina, Chinese ephedra, the root bark of white mulberry, scutellaria, perillaseed, the tuber of pinellia, almond, tussilago, Radix Glycyrrhizae is cleaned, dedusting, is dried,
Water is added to be decocted, decocts 3 times repeatedly, merges 3 decoction liquors；
(2) it is concentrated after filtering the decoction liquor obtained in step (1), ethyl alcohol is added in concentrate makes alcohol content be 80%, stirs
It mixes, stands 48h, the filtrate of filtering；
(3) it by the decompression filtrate recycling ethanol obtained in step (2) to no alcohol taste, is evaporated, crushes, 60 mesh excessively sieve to obtain Chinese medicine group
Object powder is closed, it is spare；
(4) excipient is added in the Chinese medicine composition powder for obtaining step (3), and capsule is made in mixing.
Further, first time amount of water is 8 times of medicinal material total volume in step (1), decocts 3h, and second of amount of water is
6 times of medicinal material total volume decoct 2h, and the 3rd amount of water is 5 times of medicinal material total volume, decocts 1.5h.
Further, it is 1.10 ~ 1.15 (60 DEG C) to be concentrated into relative density in step (2) after decoction liquor filtering.
Further, the excipient being added in step (4) is dextrin, and the mass ratio of Chinese medicine composition powder and dextrin is
1:3。
The Chinese medicine composition for the treatment of asthma is applied in treating asthmatic medicament.
In the present invention, the effect of each Chinese medicine material medicinal material, is as follows：
Selaginella tamariscina：Acrid flavour.It is mild-natured.Return liver, the heart channel of Hang-Shaoyin.With invigorate blood circulation；The effect of Selaginella tamariscina charcoal removing blood stasis and hemostasis.
Chinese ephedra：Acrid flavour, slight bitter.It is warm-natured.Return lung, bladder warp.Have effects that sweating cold dispelling, freeing lung and relieving asthma, inducing diuresis for removing edema.
The root bark of white mulberry：It is sweet in flavor, pungent.It is cold in nature.Return lung, the spleen channel.With removing heat from lung and relieving asthma, the effect of inducing diuresis for removing edema.
Scutellaria：It is bitter, cold in nature.Return lung, courage, spleen, large intestine, small intestinl channel.With heat-clearing and damp-drying drug, purging intense heat and detonicating, hemostasis, tocolysis
The effect of.
Perillaseed：It is acrid flavour, warm-natured.It is distributed in lung channel.Has effects that relieving cough and asthma, sending down abnormally ascending dissolving phlegm.
The tuber of pinellia：It is acrid flavour, warm-natured.Returns spleen, stomach, lung channel.With eliminating dampness and eliminating phlegm, the effect of stopping nausea and vomiting by lowering the adverse flow of QI, dissolving lump and resolving mass.
Almond：It is bitter, warm-natured.Returns spleen, stomach, large intestine channel.Have effects that it is relieving cough and asthma, relax bowel.
Tussilago：It is acrid flavour, sweet.It is warm-natured.It is distributed in lung channel.With moistening the lung and relieve the cough, under dissolving phlegm the effect of gas.
Radix Glycyrrhizae：It is sweet in flavor.It is mild-natured.The thoughts of returning home, lung, spleen, stomach.It is all with clearing heat and detoxicating, cough-relieving apophlegmatic, tonifying spleen and stomach, reconciliation
The effect of medicine.
Selaginella tamariscina has antasthmatic effect, and Chinese ephedra is as traditional relieving cough and asthma Chinese medicine, so this two tastes Chinese medicine is common
For monarch drug in a prescription, ministerial drug drops clearly lung qi with the root bark of white mulberry, scutellaria to relieving asthma, and has heat-clearing；Assistant reinforces monarch drug in a prescription with perillaseed, almond,
Depressing Qi and relieving asthma is to use, and the tuber of pinellia, tussilago are relievingd asthma with eliminating phlegm and lowering adverse QI；Make with Radix Glycyrrhizae coordinating the drug actions of a prescription, lung is given birth in tonifying spleen.
Specific implementation mode
With reference to specific example, invention is further described in detail.
Embodiment 1
A kind of capsule for treating asthma, includes the raw material components of following parts by weight：Selaginella tamariscina 25g, Chinese ephedra 15g, root bark of white mulberry 10g,
Scutellaria 10g, perillaseed 20g, tuber of pinellia 15g, almond 5g, tussilago 10g, Radix Glycyrrhizae 3g.
A kind of preparation method of above-mentioned Camellia nitidissima antiallergy capsule, includes the following steps：
(1) by Selaginella tamariscina, Chinese ephedra, the root bark of white mulberry, scutellaria, perillaseed, the tuber of pinellia, almond, tussilago, Radix Glycyrrhizae is cleaned, dedusting, is dried,
Water is added to be decocted, carries out 3 times repeatedly, obtains decoction liquor, first time amount of water is 8 times of medicinal material total volume, is decocted
3h, second of amount of water are 6 times of medicinal material total volume, decoct 2h, and the 3rd amount of water is 5 times of medicinal material total volume, is decocted
1.5h。
(2) merge 3 decoction liquors, be filtered, filtrate is concentrated, it is 1.10- to concentrate the filtrate to relative density
1.15(60℃).Ethyl alcohol is added in concentrate, it is 80% to make alcohol content, is stirred, and places 48h, is filtered.
(3) by above-mentioned decompression filtrate recycling ethanol to no alcohol taste, the sieve be evaporated, crush, crossing 60 mesh is spare.
(4) a certain amount of excipient is added in above-mentioned powder, the excipient of addition is dextrin, and the amount of addition is powder：Paste
Essence=1:3, after mixing, it is made capsule, 2.5g/.
Embodiment 2
A kind of capsule for treating asthma, includes the raw material components of following parts by weight：Selaginella tamariscina 30g, Chinese ephedra 20g, root bark of white mulberry 12g,
Scutellaria 13g, perillaseed 22g, tuber of pinellia 20g, almond 5g, tussilago 13g, Radix Glycyrrhizae 3g.
A kind of preparation method of above-mentioned Camellia nitidissima antiallergy capsule, includes the following steps：
(1) by Selaginella tamariscina, Chinese ephedra, the root bark of white mulberry, scutellaria, perillaseed, the tuber of pinellia, almond, tussilago, Radix Glycyrrhizae is cleaned, dedusting, is dried,
Water is added to be decocted, carries out 3 times repeatedly, obtains decoction liquor, first time amount of water is 8 times of medicinal material total volume, is decocted
3h, second of amount of water are 6 times of medicinal material total volume, decoct 2h, and the 3rd amount of water is 5 times of medicinal material total volume, is decocted
1.5h。
(2) merge 3 decoction liquors, be filtered, filtrate is concentrated, it is 1.10- to concentrate the filtrate to relative density
1.15(60℃).Ethyl alcohol is added in concentrate, it is 80% to make alcohol content, is stirred, and places 48h, is filtered.
(3) by above-mentioned decompression filtrate recycling ethanol to no alcohol taste, the sieve be evaporated, crush, crossing 60 mesh is spare.
(4) a certain amount of excipient is added in above-mentioned powder, the excipient of addition is dextrin, and the amount of addition is powder：Paste
Essence=1:3, after mixing, it is made capsule, 2.5g/.
Embodiment 3
A kind of capsule for treating asthma, it is made of following raw material：Selaginella tamariscina 35g, Chinese ephedra 25g, 15g parts of the root bark of white mulberry,
Scutellaria 15g, perillaseed 25g, tuber of pinellia 23g, almond 5g, tussilago 14g, Radix Glycyrrhizae 4g.
The capsule preparation method thereof of above-mentioned treatment asthma, includes the following steps：
(1) by Selaginella tamariscina, Chinese ephedra, the root bark of white mulberry, scutellaria, perillaseed, the tuber of pinellia, almond, tussilago, Radix Glycyrrhizae is cleaned, dedusting, is dried,
Water is added to be decocted, carries out 3 times repeatedly, obtains decoction liquor, first time amount of water is 8 times of medicinal material total volume, is decocted
3h, second of amount of water are 6 times of medicinal material total volume, decoct 2h, and the 3rd amount of water is 5 times of medicinal material total volume, is decocted
1.5h。
(2) merge 3 decoction liquors, be filtered, filtrate is concentrated, it is 1.10- to concentrate the filtrate to relative density
1.15(60℃).Ethyl alcohol is added in concentrate, it is 80% to make alcohol content, is stirred, and places 48h, is filtered.
(3) by above-mentioned decompression filtrate recycling ethanol to no alcohol taste, the sieve be evaporated, crush, crossing 60 mesh is spare.
(4) a certain amount of excipient is added in above-mentioned powder, the excipient of addition is dextrin, and the amount of addition is powder：Paste
Essence=1:3, after mixing, it is made capsule, 2.5g/.
Embodiment 4
A kind of capsule for treating asthma, it is made of following raw material：Selaginella tamariscina 50g, Chinese ephedra 30g, 25g parts of the root bark of white mulberry,
Scutellaria 15g, perillaseed 25g, tuber of pinellia 23g, almond 5g, tussilago 14g, Radix Glycyrrhizae 4g.
The capsule preparation method thereof of above-mentioned treatment asthma, includes the following steps：
(1) by Selaginella tamariscina, Chinese ephedra, the root bark of white mulberry, scutellaria, perillaseed, the tuber of pinellia, almond, tussilago, Radix Glycyrrhizae is cleaned, dedusting, is dried,
Water is added to be decocted, carries out 3 times repeatedly, obtains decoction liquor, first time amount of water is 8 times of medicinal material total volume, is decocted
3h, second of amount of water are 6 times of medicinal material total volume, decoct 2h, and the 3rd amount of water is 5 times of medicinal material total volume, is decocted
1.5h。
(2) merge 3 decoction liquors, be filtered, filtrate is concentrated, it is 1.10- to concentrate the filtrate to relative density
1.15(60℃).Ethyl alcohol is added in concentrate, it is 80% to make alcohol content, is stirred, and places 48h, is filtered.
(3) by above-mentioned decompression filtrate recycling ethanol to no alcohol taste, the sieve be evaporated, crush, crossing 60 mesh is spare.
(4) a certain amount of excipient is added in above-mentioned powder, the excipient of addition is dextrin, and the amount of addition is powder：Paste
Essence=1:3, after mixing, it is made capsule, 2.5g/.
Animal toxicity is tested：
1. take experiment mice 120, half male and half female, 150 ~ 200g of weight is respectively divided into three group 1 ~ 3, every group each 40, every group small
Mouse sign is good, and physiological characteristic is almost the same, is comparable.
2. the capsule that the Selaginella tamariscina for using the embodiment of the present invention 1 ~ 3 to prepare respectively to three groups of mouse treats asthma carries out gavage
Experiment, it is secondary daily, it continuously takes 15 days, observes and records the sign situation of all mouse during the experiment.
After experiment, three groups of mouse is showed no death, and 20 mouse are randomly selected in each group and are dissected,
It was found that the major organs of mouse are showed no abnormal situation, so the capsule is nontoxic, can use safely.
Clinical observation statistics is improved for the conditioning of asthma disease state：
1. case is chosen：Clinically choose the anaphylactia patient 200 made a definite diagnosis, 20 ~ 70 years old age, male 80, women
120, it is divided into three groups of experimental groups 1 ~ 4, every group 50.
2. test method：The capsule for using the embodiment of the present invention 1 ~ 4 to prepare respectively to experimental group 1 ~ 4, three times a day, often
Secondary 1,2.5g/, continuous medication 15 days observes and records the recovery situation of patient.
3. standard：Effectively：Asthma symptoms, sign disappear, and follow-up half a year is without recidivist；It is effective：Asthma symptoms are substantially reduced,
And attack times are reduced；In vain：The state of an illness is without any improvement or aggravates.
4. test data counts：
5. test result：As can be seen from the above experimental data, the capsule for the Selaginella tamariscina treatment asthma that prepared by the present invention is for roaring
The total effective rate for breathing heavily the treatment of disease is 94.5%, and 200 patients have no any adverse reaction, therefore is illustrated, volume of the invention
The capsule that cypress treats asthma is safe and effective drug, has good clinical expansion meaning.
Claims (7)
1. a kind of Chinese medicine composition for treating asthma, which is characterized in that the Chinese medicine composition by following parts by weight raw material system
At：25 ~ 50 parts of Selaginella tamariscina, 15 ~ 30 parts of Chinese ephedra, 10 ~ 25 parts of the root bark of white mulberry, 10 ~ 20 parts of scutellaria, 20 ~ 30 parts of perillaseed, 15 ~ 30 parts of the tuber of pinellia,
1 ~ 10 part of almond, 10 ~ 15 parts of tussilago, 1 ~ 5 part of Radix Glycyrrhizae.
2. a kind of Chinese medicine composition for treating asthma as described in claim 1, which is characterized in that the agent of the Chinese medicine composition
Type is capsule.
3. the preparation method of the Chinese medicine composition for the treatment of asthma as claimed in claim 2, which is characterized in that including following step
Suddenly：
(1) by Selaginella tamariscina, Chinese ephedra, the root bark of white mulberry, scutellaria, perillaseed, the tuber of pinellia, almond, tussilago, Radix Glycyrrhizae is cleaned, dedusting, is dried,
Water is added to be decocted, decocts 3 times repeatedly, merges 3 decoction liquors；
(2) it is concentrated after filtering the decoction liquor obtained in step (1), ethyl alcohol is added in concentrate makes alcohol content be 80%, stirs
It mixes, stands 48h, the filtrate of filtering；
(3) it by the decompression filtrate recycling ethanol obtained in step (2) to no alcohol taste, is evaporated, crushes, 60 mesh excessively sieve to obtain Chinese medicine group
Object powder is closed, it is spare；
(4) excipient is added in the Chinese medicine composition powder for obtaining step (3), and capsule is made in mixing.
4. the preparation method of the Chinese medicine composition for the treatment of asthma as claimed in claim 3, which is characterized in that the in step (1)
Amount of water is 8 times of medicinal material total volume, decocts 3h, and second of amount of water is 6 times of medicinal material total volume, decocts 2h, the 3rd time
Amount of water is 5 times of medicinal material total volume, decocts 1.5h.
5. the preparation method of the Chinese medicine composition for the treatment of asthma as claimed in claim 3, which is characterized in that decocted in step (2)
It is 1.10 ~ 1.15 (60 DEG C) that relative density is concentrated into after boil liquid filtering.
6. the preparation method of the Chinese medicine composition for the treatment of asthma as claimed in claim 3, which is characterized in that add in step (4)
The excipient entered is dextrin, and the mass ratio of Chinese medicine composition powder and dextrin is 1:3.
7. application of the Chinese medicine composition of asthma described in claim 1 in treating asthmatic medicament.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810480307.4A CN108420913A (en) | 2018-05-18 | 2018-05-18 | A kind of Chinese medicine composition and preparation method thereof for treating asthma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810480307.4A CN108420913A (en) | 2018-05-18 | 2018-05-18 | A kind of Chinese medicine composition and preparation method thereof for treating asthma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108420913A true CN108420913A (en) | 2018-08-21 |
Family
ID=63163705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810480307.4A Pending CN108420913A (en) | 2018-05-18 | 2018-05-18 | A kind of Chinese medicine composition and preparation method thereof for treating asthma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108420913A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109260340A (en) * | 2018-10-19 | 2019-01-25 | 江苏康缘药业股份有限公司 | A kind of Chinese medicine composition and preparation method and application |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1704100A (en) * | 2004-05-27 | 2005-12-07 | 江西省药物研究所 | Chinese compound medicinal preparation for treating asthma and method for preparing the same |
| CN101229236A (en) * | 2008-02-25 | 2008-07-30 | 北京金方华医药科技有限公司 | Relieve asthma oral liquid preparation and preparing method thereof |
| CN102078462A (en) * | 2010-10-08 | 2011-06-01 | 刘淑平 | Asthma relieving medicament |
-
2018
- 2018-05-18 CN CN201810480307.4A patent/CN108420913A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1704100A (en) * | 2004-05-27 | 2005-12-07 | 江西省药物研究所 | Chinese compound medicinal preparation for treating asthma and method for preparing the same |
| CN101229236A (en) * | 2008-02-25 | 2008-07-30 | 北京金方华医药科技有限公司 | Relieve asthma oral liquid preparation and preparing method thereof |
| CN102078462A (en) * | 2010-10-08 | 2011-06-01 | 刘淑平 | Asthma relieving medicament |
Non-Patent Citations (3)
| Title |
|---|
| 刘延君，靳洪年，杨艳红，贾孟辉: "自拟热哮方治疗支气管哮喘急性发作58例", 《河北中医药学报》 * |
| 李春深: "《常见病的治疗方法》", 31 January 2018, 天津科学技术出版社 * |
| 胡炳义: "《祛风湿强筋骨中草药妙用》", 31 January 2016, 军事医学出版社 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109260340A (en) * | 2018-10-19 | 2019-01-25 | 江苏康缘药业股份有限公司 | A kind of Chinese medicine composition and preparation method and application |
| CN109260340B (en) * | 2018-10-19 | 2024-01-19 | 江苏康缘药业股份有限公司 | Traditional Chinese medicine composition and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104225441A (en) | Traditional Chinese medicine composition for treating stomach trouble and preparation method of granules and capsules of traditional Chinese medicine composition | |
| CN104383183A (en) | Medicinal composition for treating non-alcoholic fatty liver | |
| CN111298021A (en) | Traditional Chinese medicine composition for treating functional constipation | |
| CN108420913A (en) | A kind of Chinese medicine composition and preparation method thereof for treating asthma | |
| CN103316175B (en) | Traditional Chinese medicine powder, and preparation method and application thereof | |
| CN105327163A (en) | Preparation used for treating nephrotic syndromes and achieving dampness resolving and detumescence and preparation method | |
| CN104524481A (en) | Traditional Chinese medicine for treating irritable bowel syndrome and preparation method thereof | |
| CN104162093A (en) | Traditional Chinese medicinal preparation for treating breast cancer, and preparation method thereof | |
| CN104162097B (en) | A kind of Chinese medicine preparation for being used to treat cholelithiasis complicated with fatty liver | |
| CN107441401A (en) | Chinese medicine composition for three high drop and preparation method thereof | |
| CN102805834A (en) | Drug for curing gastritis and preparation method thereof | |
| CN105106710A (en) | Preparing method of lung-moistening and phlegm-removing preparation for treating asthma | |
| CN107854662A (en) | A kind of Chinese medicine preparation for treating cirrhotic ascites and preparation method thereof | |
| CN103735906A (en) | Chinese herb preparation for treating dry bronchiectasis and preparation method thereof | |
| CN107913389A (en) | A kind of Chinese medicine composition for treating Thyroid Gland Swell and preparation method thereof | |
| CN103330861B (en) | Medicine for curing cholera and preparation method thereof | |
| CN105727243A (en) | Chinese herbal composition for treating myocarditis and preparing method of Chinese herbal composition | |
| CN105709193A (en) | Artemisia argyi Levl-containing traditional Chinese medicine preparation for treating chronic enteritis and preparation method thereof | |
| CN104784567B (en) | A kind of pharmaceutical composition for the treatment of urinary system infection | |
| CN106166251A (en) | A kind of for Chinese medicine preparation treating asthma and preparation method thereof | |
| CN105267940A (en) | Traditional Chinese medicine composition for preventing and treating gastric ulcer and preparation method thereof | |
| CN105267815A (en) | Spray for treating infant lung-kidney-deficiency type asthma and preparing method thereof | |
| CN105010673A (en) | Alcohol-dispelling Chinese herbal tea substitute decoction and preparation method thereof | |
| CN104435152A (en) | Traditional Chinese medicine agent with functions of tranquilizing and allaying excitement for treating stage I of hypertension and preparation method | |
| CN104800548B (en) | A kind of Chinese medicine composition for treating pulmonary emphysema |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180821 |